$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Fatty acid treatment 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/20
출원번호 US-0721329 (1996-09-26)
우선권정보 GB-0019661 (1995-09-27)
발명자 / 주소
  • Vaddadi Krishna S,AUX
출원인 / 주소
  • Scotia Holdings Plc, GBX
대리인 / 주소
    Nixon & Vanderhye
인용정보 피인용 횟수 : 81  인용 특허 : 0

초록

A method of treating Huntington's Chorea by the administration of effective amounts of GLA or DGLA and a method of delaying the onset of Huntington's Chorea or preventing it altogether by administering appropriate amounts of GLA or DGLA to clinically normal individuals who are genetic carriers of th

대표청구항

[ I claim:] [1.] A method of treating the symptoms of Huntington's Chorea comprising administering to a patient in need of same an effective amount of gamma-linolenic acid (GLA) or dihomogammalinolenic acid (DGLA).

이 특허를 인용한 특허 (81)

  1. Strohmaier,George K.; Luchini,Nestor D.; Varcho,Michael A.; Frederiksen,Eiler D., Calcium salt saponification of polyunsaturated oils.
  2. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject.
  3. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides.
  4. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy.
  5. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy.
  6. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
  7. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
  8. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
  9. Zakrzewski, Joseph S., Compositions and methods for treating or preventing obesity in a subject in need thereof.
  10. Zakrzewski, Joseph S., Compositions and methods for treating or preventing obesity in a subject in need thereof.
  11. Zakrzewski, Joseph S., Compositions comprising EPA and obeticholic acid and methods of use thereof.
  12. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof.
  13. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof.
  14. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof.
  15. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof.
  16. Chilton, Floyd; Lu, Fan, Compositions, methods, and kits for polyunsaturated fatty acids from microalgae.
  17. Galvez,Juan Miguel Garro; Angers,Paul; Briand,Sandie, Conjugated linolenic acids and methods of preparation and purification and uses thereof.
  18. Harbige, Laurence S.; Leach, Michael J.; Barraclough, Paul; Dolan, Anthony P, Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids.
  19. Peet, Malcolm; Vaddadi, Krishna S., Highly purified ethyl EPA and other EPA derivatives.
  20. Peet,Malcolm; Vaddadi,Krishna S, Highly purified ethyl EPA and other EPA derivatives for treatment of huntington's disease.
  21. Hertha, David W., Method for treating diseases of fungal, yeast, and prion protein etiology.
  22. Chilton, Floyd H., Methods and compositions for the treatment of asthma.
  23. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
  24. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Zakrzewski, Joseph S., Methods of reducing apolipoprotein C-III.
  25. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Zakrzewski, Joseph S., Methods of reducing apolipoprotein C-III.
  26. Mason, Richard Preston, Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids.
  27. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  28. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  29. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  30. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  31. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  32. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  33. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  34. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  35. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
  36. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  37. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  38. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  39. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  40. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  41. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  42. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  43. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  44. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  45. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  46. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  47. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  48. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  49. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  50. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  51. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Breackman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
  52. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  53. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  54. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  55. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  56. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
  57. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Pharmaceutical compositions comprising fatty acids.
  58. Horrobin David Frederick,GBX, Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid.
  59. Horrobin, David Frederick, Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid.
  60. Luchini, Daniel Nestor; Strohmaier, George K.; Frederiksen, Eiler D.; Hawkes, James G.; Dull, Bob J., Polyunsaturated fatty acid monovalent and divalent metal salt synthesis.
  61. Manku, Mehar, Stable pharmaceutical composition and methods of using same.
  62. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  63. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  64. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  65. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  66. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  67. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  68. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  69. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  70. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  71. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  72. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  73. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  74. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  75. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  76. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  77. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  78. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  79. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  80. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
  81. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로